Primary cardiac lymphoma in a heart transplant recipient

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 1362-1364

  Nart, D ^a   Nalbantgil, S ^a,b   Yagdi, T ^a   Yilmaz, F ^a   Hekimgil, M ^a   Yuce G ^a   Hamulu, A ^a  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; PREDNISONE;

ABDOMINAL DISEASE; ADULT; AUTOPSY; B CELL LYMPHOMA; CARDIAC GRAFT REJECTION; CASE REPORT; CAUSE OF DEATH; CLINICAL EXAMINATION; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LARGE CELL LYMPHOMA; LIVER FUNCTION TEST; MALE; MULTIPLE ORGAN FAILURE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL;

EID: 17844409605     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.01.034     Document Type: Conference Paper

References (24)

1. R.C. Walker, C.V. Paya, W.F. Marshall Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations J Heart Lung Transplant 14 1995 214
2. J.M. Armitage, R.L. Kormos, R.S. Stuart Posttransplantation lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression J Heart Lung Transplant 10 1991 877
3. L.J. Swinnen, M.R. Constanza-Nordin, S.G. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients N Engl J Med 323 1990 1723
4. G. Opelz, R. Henderson Collaborative Transplant Study: incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 1993 1514
5. L.J. Swinnen, G.M. Mullen, T.J. Carr Aggressive treatment for postcardiac transplant lymphoproliferation Blood 86 1995 3333
6. M.A. Nalesnik, R. Jaffe, T.S. Starzl The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression Am J Pathol 133 1988 173
7. D.M. Knowles, E. Cesarman, A. Chadburn Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders Blood 85 1995 552
8. L. Young, C. Alfieri, K. Heennessy Expression of Epstein-Barr virus transformation-associated genes in tissue of patients with EBV lymphoproliferative disease N Engl J Med 321 1989 1080
9. I. Penn The changing patterns of post-transplant malignancies Transplant Proc 23 1991 375
10. S.M. Cockfield, J.K. Preiksaitis, L.D. Jewell Posttransplant lymphoproliferative disorder in renal allograft recipients Clinical experience and risk factor analysis in a single centre Transplantation 56 1993 88
11. D.F. Patton, C.W. Wilkowski, C.A. Hanson Epstein-Barr virus determines clonality in post-transplant lymphoproliferative disorders Transplantation 49 1990 1080
12. P.S. Randhawa, R. Jaffe, A.J. Demetris Expression of Epstein-Barr virus encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with posttransplantation lymphoproliferative disease N Engl J Med 327 1992 1710
13. N.L. Harris, J.A. Ferry, S.H. Swerdlow Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop Semin Diagn Pathol 14 1997 8
14. B.P. Nelson, M.A. Nalesnik, D.W. Bahler Epstein-Barr virus negative posttransplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 24 2000 375
15. A. Chadburn, J.M. Chen, D.T. Hsu The morphometric and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant Cancer 82 1998 1978
16. A. Chadburn, E. Cesarman, D.M. Knowles Molecular pathology of posttransplantation lymphoproliferative disorders Semin Diagn Pathol 14 1997 15
17. S.H. Swedlow Classification of the posttransplant lymphoproliferative disorders: from the past to present Semin Diagn Pathol 14 1997 2
18. J. Cohen Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency Medicine 70 1991 137
19. A.J. Ying, P.D. Myerowitz, W.L. Marsh Posttransplantation lymphoproliferative disorder in cardiac transplant allografts Ann Thorac Surg 64 1997 1822
20. D.J. Weissman, J.A. Ferry, N.L. Harris Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumor of host origin Am J Clin Pathol 103 1995 748
21. H. Abu-Farsakh, P.T. Cagle, G.J. Buffone Heart allograft involvement with Epstein-Barr virus associated posttransplant lymphoproliferative disorder Arch Pathol Lab Med 116 1992 93
22. P. Burtin, A. Guerci, F. Boman Malignant lymphoma in the donor heart after heart transplantation Eur Heart J 14 1993 1143
23. R.K. Sibley, M.T. Olivari, R.M. Bolman Endomyocardial biopsy in the cardiac allograft recipient: a review of 570 biopsies Ann Surg 203 1986 177
24. H.J. Eisen, D. Hicks, J.A. Kant Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient J Heart Lung Transplant 13 1994 241